At Rivas, compounded semaglutide may be prescribed when clinically appropriate, under provider supervision
It suggests either the platform improved significantly after late 2024, or positive Trustpilot reviews are not representative of the full customer experience
UHC's formulary tiers for weight loss medication generally place GLP-1 agonists on Tier 4 (specialty) or Tier 5 (non-preferred specialty), which carries higher copay or coinsurance amounts
These ideas are in the early stages, and there havent been any clinical trials to test them
If necessary, referral to a neurologist or memory clinic may be considered, particularly if there are concerns about underlying neurodegenerative disease
It is not FDA-approved for weight loss and is used off-label, typically positioned as one piece of a broader compounded fat-loss protocol